NEORX CORPORATION CHANGE OF CONTROL AGREEMENTChange of Control Agreement • October 19th, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances
Contract Type FiledOctober 19th, 2004 Company IndustryThis Change of Control Agreement (this “Agreement”), dated as of October 25, 2004, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 13, the “Company”), and Susan D. Berland (the “Executive”).
NEORX CORPORATION KEY EXECUTIVE SEVERANCE AGREEMENTKey Executive Severance Agreement • October 19th, 2004 • Neorx Corp • In vitro & in vivo diagnostic substances
Contract Type FiledOctober 19th, 2004 Company IndustryThis Key Executive Severance Agreement (VP) (this “Agreement”), dated as of October 25, 2004, is entered into by and between NEORX CORPORATION, a Washington corporation (as supplemented by Section 10, the “Company”), and Susan D. Berland (the “Executive”).